Metformin (1000mg) + Teneligliptin (20mg)
Vidglit-M Forte Tablet ER is used in the treatment of type 2 diabetes.
10 tablet er in 1 strip
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Vidglit-M Forte Tablet ER is to be taken with food.
Vidglit-M Forte Tablet ER may cause stomach upset if taken on empty stomach.
Vidglit-M Forte Tablet ER is a combination of two antidiabetic medicines: Metformin and Teneligliptin. Metformin is an antidiabetic medication (biguanide). It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body"s sensitivity to insulin. Teneligliptin is a dipeptidyl peptidase-4 inhibitor which works by increasing the release of insulin from pancreas and decreasing the hormones that raise blood sugar levels. This reduces both fasting and postmeal sugar levels. Together, they provide better control of blood sugar.
Related Warnings
Taking metformin with alcohol can cause lactic acidosis and you may experience malaise, respiratory distress, slow or irregular heartbeat, sleepiness, stomach upset, or other unusual symptoms.
Unknown. Human and animal studies are not available. Please consult your doctor.
No information is available on the use of Vidglit-M Forte Tablet ER during lactation. Please consult your doctor.
Your ability to drive may be affected if your blood sugar is low or high. If this happens, do not drive.
Vidglit-M Forte Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Vidglit-M Forte Tablet ER may be needed. Please consult your doctor.
Use of Vidglit-M Forte Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Vidglit-M Forte Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Vidglit-M Forte Tablet ER may be needed. Please consult your doctor.
Vidglit-M Forte Tablet ER is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.